GREENWICH LIFESCIENC
GLSI
 Delayed - 01/19 04:00:00 pm |
|
| 37.27USD | -0.48% |
Income Statement Evolution
Annual Income Statement Data
| Fiscal Period: December | 2018 | 2019 |
| Net sales | - | - |
| EBITDA1 | -1,69 | -3,42 |
| Operating profit (EBIT)1 | -1,69 | -3,43 |
| Operating Margin | - | - |
| Pre-Tax Profit (EBT)1 | -1,69 | -3,43 |
| Net income1 | -1,69 | -3,43 |
| Net margin | - | - |
| EPS2 | -8,32 | -1,52 |
| Dividend per Share | - | - |
| Last update | 05/29/2020 | 05/29/2020 |
|
1 USD in Million 2 USD |
||
Finances - Leverage
| Fiscal Period: December | 2018 | 2019 |
| Net Debt1 | 0,34 | 0,63 |
| Net Cash position1 | - | - |
| Leverage (Debt / EBITDA) | -0,20x | -0,18x |
| Free Cash Flow | - | -1,51 |
| ROE (Net Profit / Equities) | - | 59,7% |
| Shareholders' equity1 | - | -5,74 |
| ROA (Net Profit / Asset) | - | -3 167% |
| Assets1 | - | 0,11 |
| Book Value Per Share2 | -49,9 | -0,16 |
| Cash Flow per Share2 | 0,42 | 0,00 |
| Capex | - | - |
| Capex / Sales | - | - |
| Last update | 05/29/2020 | 05/29/2020 |
|
1 USD in Million 2 USD |
||
Balance Sheet Analysis
EPS & Dividend
